GlassScriptPhysician profile
Matthew J Watson
NPI 1275066441
$3,125.69
in general payments reported to CMS, 2019-2025
13 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,069 · 2023: $431 · 2024: $357 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886 · Travel and Lodging: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.34 |
| Travel and Lodging | $170.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,697.87 | 2022-2023 | Titan, Isiris Astent Removal Device |
| Teleflex LLC | $506.93 | 2023-2025 | Urolift |
| Medtronic, INC. | $355.23 | 2022-2023 | Interstim |
| Boston Scientific Corporation | $204.23 | 2022-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Axonics, INC. | $96.58 | 2023-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $60.37 | 2025 | Gemtesa |
| Janssen Biotech, INC. | $54.27 | 2024-2025 | Erleada |
| Urogen Pharma, INC. | $35.33 | 2024 | |
| Progenics Pharmaceuticals, INC. | $28.61 | 2025 | |
| Endo USA, INC. | $26.93 | 2025 | Aveed, Xiaflex |
| Accord Healthcare, INC. | $23.59 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.51 | 2025 | |
| Abbvie INC. | $16.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.